Carregant...

Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments

Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Mehdi Arbabi-Ghahroudi
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2022-04-01
Col·lecció:International Journal of Molecular Sciences
Matèries:
VHH
Accés en línia:https://www.mdpi.com/1422-0067/23/9/5009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!